Accession Number : ADA501627


Title :   Modification of Tamoxifen Effectiveness by Gene Polymorphisms and Other Drugs


Descriptive Note : Annual summary rept. 15 Apr 2008-14 Apr 2009


Corporate Author : TRUSTEES OF BOSTON UNIV MA


Personal Author(s) : Ahern, Thomas P


Full Text : http://www.dtic.mil/dtic/tr/fulltext/u2/a501627.pdf


Report Date : May 2009


Pagination or Media Count : 43


Abstract : In the first year of his predoctoral award, Thomas Ahern completed all coursework and qualifying examinations required for entry into the senior phase of doctoral study for the Doctor of Science degree in epidemiology at Boston University. Mr. Ahern submitted a dissertation research proposal to the Epidemiology Doctoral Committee in May 2008; the proposal was formally approved in October 2008. Mr. Ahern completed and published one of the three studies of his dissertation research in December 2008, an investigation of the effects of cardiac glycoside treatment on breast cancer risk. Mr. Ahern has supervised the ongoing collection and processing of biological samples required for his second and third dissertation projects. These studies are on track for completion in 2010. Meanwhile Mr. Ahern has published several other breast cancer research papers as a supplement to his training program.


Descriptors :   *GENES , *GLYCOSIDES , *DRUGS , *POLYMORPHISM , *BREAST CANCER , CARDIAC GLYCOSIDES , MAMMARY GLANDS , HEART , RISK , EPIDEMIOLOGY


Subject Categories : Biochemistry
      Medicine and Medical Research
      Pharmacology
      Crystallography


Distribution Statement : APPROVED FOR PUBLIC RELEASE